SLC22A3 and head and neck squamous cell carcinoma: Therefore, in this study, we elucidated the effect of SLC22A3 expression on cisplatin uptake by HNSCC cells with overexpression or knockdown of SLC22A3. The survival was assessed to evaluate the response to chemotherapy of patients and to determine the correlation between the response and their expression levels of SLC22A3.